Miele energy tablets

Safety data sheet
According to EC Directive 2001/58/EEC
Identification of the substance/preparation and of the company/undertaking
Identification of the substance/preparation
Miele energy tablets
with glass care formula

Use of the substance/preparation
Company/undertaking information
claro products GmbH
Vogelsangstraße 1
A-5310 Mondsee
Telefon: 06232-2626

Emergency telephone
Date of issue/revision
Composition/Information on ingredients
Chemical characterization (specification)
2.1.1 CAS-No. description according to EC Directive 2.2. Chemical characterization (preparation)
2.2.1. Hazardous ingredients
2.2.2. Additional information
Hazards Identification
Classification according to §3 Chemical Law
Characterization of hazards
Special hazards to human health
and the environment

Operates mainly due to its irritating properties First aid measures
General recommendations
After inhalation
After skin contact
After eye contact
rinse eyes immediately with plenty of water while keeping the eyelids wide open; consult an ophthalmologist After ingestion
rinse mouth and make person to drink plenty of water (only if the person is conscious); do not induce vomiting; seek medical advice Advice to doctor
Fire fighting measures
Suitable extinguishing media
Improper extinguishing media
Specific hazards through substance,
products or gas originating from combustion

Special protective equipment
Further information
Accidental release measures
Environmental precautions
Do not empty into drains (sewerage system, rivers, soils, etc.) but fill into tightly closed containers Miele energy tablets with GCF - page 1/4 ± printed: 28.11.2006/revised: 07.11.2006 - cl
Safety data sheet
According to EC Directive 2001/58/EEC
Methods for cleaning up/taking up
After spilling/leaking (little amounts) clean area with Additional information
Handling and storage
In case of proper use, no specific measures are necessary Requirements for storage rooms and vessels Further information on storage conditions Exposure controls and personal protection
Additional information on fitting technical facilities -
Exposure limit values
CAS-No., Hazardous ingredient, Code, Value, Unit Personal protective equipment
Contact with moist skin may cause irritation; use protective gloves if necessary Do not eat or drink while using the product;wash hands after work or before breaks Physical and chemical properties
General information
Health, safety and environmental information
9.2.13 Partition coefficient n-Octanol/water Further information
Stability and reactivity
Conditions to avoid
Materials to avoid
Hazardous decomposition products
Further information
Toxicological information
Toxicological test
Miele energy tablets with GCF - page 2/4 ± printed: 28.11.2006/revised: 07.11.2006 - cl
Safety data sheet
According to EC Directive 2001/58/EEC
11.1.5 Effect after repeating or long-term exposure Practical experience
11.2.1. Observation relevant to classification 11.3. General remarks
Ecological information
Data on elimination (persistence and degradability)
12.1.1 Physico-chemical12.1.1.1 Method Procedure in environmental compartments
In case of proper discharge (little concentration) into well adapted sewage treatment plants, no obstructions of the activated sludge activity occur Ecotoxical effects
12.3.2 Reaction in sewage treatment plants Bioaccumulative potential
12.5.5 General
Do not allow the undiluted product to enter the seweragesystem Disposal considerations
Dispose of this material to hazardous or special waste collection point, as chemical-physical or thermic treatment may be required Contaminated packaging
Dispose of contaminated packaging according to regulations of local authorities Transport information
Land transport ADR/RID and GGVS/GGVE
Inland waterway transport ADN/ADNR
Sea transport IMDG/GGVSea
Miele energy tablets with GCF - page 3/4 ± printed: 28.11.2006/revised: 07.11.2006 - cl
Safety data sheet
According to EC Directive 2001/58/EEC
Air transport ICAO-TI and IATA-DGR
14.5. Transport / further information

Regulatory information
Labelling according to EC-regulations
The product has been classified and labelled according to EC directives 15.1.2 Hazards symbols and hazard classification S2 ± Keep out of the reach of childrenS26 ± In case of contact with eyes, rinse immediately with plenty of water and seek medical adviceS39 ± Wear eye/face protectionS46 ± If swallowed, seek medical advice immediatelyand show this container or label Contains Protease, may cause allergic reactions.
National regulations
15.2.3 Classification according to VbF/remarks Other information
SDS of suppliers, own lab data, RÖMPP, Kühn-Birett and Gestis-Material data bank Abbreviations:
List of relevant R-phrases (see pt. 2 and 3 of SDS)
R8 ± Contact with combustible material may cause fireR22 ± Harmful if swallowedR36 ± Irritating to eyesR37 ± Irritating to respiratory systemR36/38 ± Irritating to eyes and skinR38 ± Irritating to skinR41 ± Risk of serious damage to eyesR42 ± May cause sensitisation by inhalationR52/53 ± Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment Changes to the previous SDS are marked by frames.
The information of this safety data sheet is based on the present state of our knowledge and experience. It
characterizes the product with regard to the appropriate safety precaution. It does not represent a guarantee of
the properties of the product.

Miele energy tablets with GCF - page 4/4 ± printed: 28.11.2006/revised: 07.11.2006 - cl

Source: http://www.miele.co.uk/downloads/SafetyFiles/06848090_EN_SafetyDataSheet_2006_11.pdf

Mx of chronic pelvic pain

MANAGEMENT OF CHRONIC PELVIC PAIN By Tim Chang o pain >6 months duration, o below the umbilicus o affecting daily activities accounts for 10% gynaecology visits 20% hysterectomies primary indication CPP 40% all laparoscopies performed fro CPP 40% cases there is NO obvious pathology in an adolescent there is increased likelihood of pathology∴ need to assess more aggressively A

Lgd distributions.pdf

In any form of portfolio analysis, it is appropriate to regard some inputs as stochastic and others as deterministic. In areas where key inputs are uncertain, it may be more suitable to map such inputs to a distribution than to “guess” an average result. This however increases the modelling complexity in terms of the sampling precedence that will occur in the simulation process, and increa

Copyright © 2018 Medical Abstracts